Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abetted, accreted, Accretion, advocated, AI, Allied, Amgen, Argentina, arisen, artificial, ascending, assignee, ATG, Australia, automated, bad, benchmark, BML, bona, Braden, branch, Cable, CAGR, Camac, campaign, Canada, Car, cast, Ch, Chevron, China, Chinese, classification, consecutive, contemplated, coordinating, counting, creditworthy, cybersecurity, Deadline, deceit, declaratory, Del, depigmentation, detachable, detriment, diarrhea, Diego, dissuade, double, Dr, Draft, East, embodying, encryption, entirety, entrenchment, entry, Eric, exit, expedite, expedited, factor, faith, fide, Florida, frame, freestanding, Funicular, Gabriel, Gliksberg, GP, GU, Hacke, hardware, heard, hearing, hereinafter, ID, intelligence, Interagency, interfered, introduced, IRA, irrevocable, issuable, Jacob, jaundice, KPMG, Leonard, LLP, longstanding, LP, mandatorily, manifest, manipulating, manual, McIntyre, Michael, misinformation, Mkt, motion, mucosal, muscle, NIST, nominal, password, patching, PCT, penny, permanent, Plaintiff, posture, prefunded, PSLRA, PTA, rash, recurring, regain, reply, resurgence, retaliation, San, Sanofi, seq, Shahinian, sixteenth, smearing, software, solve, Speedy, stay, subunit, swing, Taiwan, Tex, thereon, thirteen, threat, tied, title, tortiously, unchanged, undermine, Unified, Unitary, unspecified, UPC, validly, voluntarily, vomiting, waived
Filing tables
Filing exhibits
Related press release
FBRX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-274257 and 333-256611 on Form S-3 and in Registration Statement Nos. 333-271036, 333-265823, 333-255125, 333-244407, 333-235852, 333-229963, 333-223558 and 333-217300 on Form S-8 of our report dated March 31, 2023, with respect to the consolidated financial statements of Forte Biosciences, Inc. as of and for the year ended December 31, 2022, included in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 18, 2024